Modern Clinical Supply Strategies and Ensuring Effective Solutions to be Discussed by Catalent Experts at GCSG Virtual
On Sept. 21, at 12 p.m. EDT, Mark Woolf, Director, Depot Networks, will lead a workshop titled “Distribution Planning and the Role of Depots post COVID-19”. Mr. Woolf will discuss the requirements for current clinical supply chain distribution planning, explaining instances where depots, as well as a knowledge of customs’ requirements are essential, and how the pandemic has affected the structure of supply chains.
Expanding access to patient populations, faster recruitment, increasing patient retention and decreasing time to market are all reasons that sponsors are exploring direct-to-patient clinical trial supply models. In her workshop titled “Direct-to-Patient Distribution – The New Normal?”, on Sept. 22, at 11 a.m. EDT, Nicole Gray, Director, Strategic Supply Solutions, will lead a discussion on the benefits and risks that should be considered when planning a robust direct-to-patient supply chain model.
On Sept. 22, at 11 a.m. EDT, Kristen Devito, Vice President of Customer Service Excellence, Clinical Supply Services, and Stephanie Graham, Regional Manager, Clinical Supply Management, will lead a workshop on “Protocol Interpretation for Clinical Supply Design: A Case Study”. The session will use a case study to demonstrate the key processes that are needed to ensure effective protocol interpretation in complex trials to optimize clinical supply.
The workshops will be repeated throughout the conference, and Catalent will also showcase its clinical supply solutions as part of the virtual exhibition and networking sessions at the event. For more information, please visit: https://www.clinical.catalent.com/events/gcsg-2020-global-virtual-conference.
Notes for Editors
ABOUT CATALENT CLINICAL SUPPLY SERVICES
Catalent is a global leader in clinical supply services, with comprehensive and flexible solutions for small molecules, biologics, and cell and gene therapies and integrated solutions to accelerate speed to clinic. Catalent offers a full range services including clinical supply management, comprehensive packaging solutions, comparator sourcing, cold chain storage and global distribution and specialized supply chain services including direct-to-patient and demand-led supply. With nine GMP clinical packaging facilities and over 50 strategically located depots on six continents combined with more than 25 years’ experience across thousands of studies in more than 80 countries, Catalent has the comprehensive services, global scale and expertise necessary to reliably supply clinical trials of all sizes and complexity anywhere in the world.
Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs approximately 14,000 people, including around 2,400 scientists and technicians, at more than 45 facilities, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com